Designer nuclease‐mediated gene correction via homology‐directed repair in an in vitro model of canine hemophilia B. (3rd May 2018)

• Record Type: Journal Article
• Authors: Bergmann, Thorsten; Ehrke-Schulz, Eric; Gao, Jian; Schiwon, Maren; Schildgen, Verena; David, Stephan; Schildgen, Oliver; Ehrhardt, Anja
• Is Part Of: Journal of gene medicine. Volume 20:Number 5(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-05-03
• Subjects: gene – editing -- gene – therapy -- Haemophilia/ hemophilia -- molecular – genetics -- vector ‐ nonviral; Genetic transformation -- Periodicals; Gene Transfer -- Periodicals; Gene Therapy -- Periodicals; 616.042
• DOI: 10.1002/jgm.3020
• Languages: English
• ISSNs: 1099-498X

Abstract

Abstract: Background: Gene correction at specific target loci provides a powerful strategy for overcoming genetic diseases. In the present study, we aimed to use an in vitro model for canine hemophilia B containing a single point mutation in the catalytic domain of the canine coagulation factor IX ( cFIX ) gene. To correct the defective gene via homology‐directed repair (HDR), we designed transcription‐activator like effector nucleases and clustered regularly interspaced short palindromic repeats including Cas9 (CRISPR/Cas9) for introduction of double‐strand breaks at the mutation site. Methods: To generate a stable cell line containing the mutated cFIX locus, a 2‐kb genomic DNA fragment derived from a hemophilia B dog was amplified and integrated utilizing the phiC31 integrase system. Designer nucleases were assembled and cloned into vectors for constitutive and inducible expression. To detect mutations, insertions and deletions, and HDR events after nuclease treatment T7E1 assays, an amplification‐refractory mutation system‐quantitative polymerase chain reaction and pyrosequencing were performed. Results: To perform HDR correction experiments, we established a cell line carrying the mutated cFIX locus. In HDR approaches we either explored a wild‐type or an optimized cFIX sequence and we found that our modified HDR cassette showed higher gene correction efficiencies of up to 6.4%. Furthermore, we compared inducible and constitutive designer nuclease expression systems and found that the inducible system resulted in comparable HDR efficiencies. Conclusions: In conclusion, the present study demonstrates the potential of this strategy for gene therapeutic approaches in vitro and in a canine model for hemophilia B.